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Abstract
Guide RNA molecules (crRNA) produced from clustered regularly interspaced short palin-
dromic repeat (CRISPR) arrays, altogether with effector proteins (Cas) encoded by cognate
cas (CRISPR associated) genes, mount an interference mechanism (CRISPR-Cas) that
limits acquisition of foreign DNA in Bacteria and Archaea. The specificity of this action is pro-
vided by the repeat intervening spacer carried in the crRNA, which upon hybridization with
complementary sequences enables their degradation by a Cas endonuclease. Moreover,
CRISPR arrays are dynamic landscapes that may gain new spacers from infecting ele-
ments or lose them for example during genome replication. Thus, the spacer content of a
strain determines the diversity of sequences that can be targeted by the corresponding
CRISPR-Cas system reflecting its functionality. Most Escherichia coli strains possess either
type I-E or I-F CRISPR-Cas systems. To evaluate their impact on the pathogenicity of the
species, we inferred the pathotype and pathogenic potential of 126 strains of this and other
closely related species and analyzed their repeat content. Our results revealed a negative
correlation between the number of I-E CRISPR units in this system and the presence of
pathogenicity traits: the median number of repeats was 2.5-fold higher for commensal iso-
lates (with 29.5 units, range 0–53) than for pathogenic ones (12.0, range 0–42). Moreover,
the higher the number of virulence factors within a strain, the lower the repeat content. Addi-
tionally, pathogenic strains of distinct ecological niches (i.e., intestinal or extraintestinal) dif-
fer in repeat counts. Altogether, these findings support an evolutionary connection between
CRISPR and pathogenicity in E. coli.
Introduction
CRISPR-Cas systems are composed of at least one array of clustered regularly interspaced
short palindromic repeats (CRISPR) and a set of cas (CRISPR-associated) genes [1,2]. Several
CRISPR-Cas types (denoted I, II and III) and subtypes (identified with an additional letter) are
distinguished according to the identity of the associated cas genes [3]. Although diverse tenta-
tive functions were initially postulated for particular systems [4–7], it has been demonstrated
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that they constitute an RNA-based interference mechanism that prokaryotes may utilize to
avert infection by foreign genetic elements [8,9]. In brief, during encounters with invading
DNA, short external sequences known as protospacers are integrated into a genomic CRISPR
array through the acquisition process, becoming new repeat-intervening spacers [8,10–12].
This incorporation generally takes place at the end next to the leader [2,8,13–15], defined as an
AT-rich sequence that usually, with the known exception of one type II system variant [16],
governs transcription of the adjacent repeat-spacer array [14,17]. Afterwards, newly incorpo-
rated genetic elements with target regions matching spacer sequences will be degraded in the
interference stage after annealing of the target with the complementary sequence in processed
mono-spacer CRISPR RNA (crRNA) molecules [18,19]. These three main steps of CRISPR-
Cas mechanism (spacer acquisition, crRNA processing and interference) require Cas proteins
coded by the cas genes that are part of the system [19].
As a result of the diverse encounters that a cell lineage has experienced, the spacer content
(number of spacers and their particular sequence) of a given CRISPR locus may vary greatly
among closely related isolates. Moreover, the number of repeat-spacer units might be influ-
enced by factors such as intrinsic acquisition activity, CRISPR-Cas expression levels or func-
tionality of the Cas proteins in general [20–23]. Indeed, CRISPR-carrying strains that lack
associated cas genes and/or leader show a reduced repeat number when compared to otherwise
similar complete systems [15,21,23–25]. Furthermore, the acquisition efficiency in repeat
arrays of a given CRISPR system varies in line with the leader expression level and repeat
sequence conservation [26]. Thus, the complexity of a CRISPR array appears to mirror its over-
all activity.
CRISPR-Cas systems of I-E and I-F subtype may be found in Escherichia coli. However,
some E. colimembers lack the corresponding cas genes (cas I-E and I-F respectively) and only
in very rare occasions are both simultaneously found [21,24]. Based on an early classification
proposed by Kunin and coworkers [27], the CRISPR units of the I-E and I-F systems are as-
signed to clusters 2 and 4, respectively, of repeat types (here denoted CRISPR2 and CRISPR4).
CRISPR2 are organized in E. coli in up to three arrays, accordingly named CRISPR2.1 (in
CRISPR I locus, adjacent to the cas I-E genes), CRISPR2.2 and CRISPR2.3. The two latter
arrays are located in the CRISPR II region, at a distance of 24 kb from CRISPR I. Occasionally
a single array is found in CRISPR II, therefore called CRISPR2.2–3 [24]. Whereas CRISPR2.2 is
constituted by 3 repeats and two invariable spacers, an analysis of 100 strains of the species dis-
closed up to a ten-fold difference (2–3 to 29–30) of repeat counts in CRISPR2.1 and CRISPR2.3
of systems with associated cas I-E genes [24]. Even though this diversity of CRISPR2 spacers
is remarkable and the functionality of the I-E system has been demonstrated in a few E. coli
strains [17,20,28,29], its role as a relevant genetic barrier in E. coli remains uncertain [24,28,
30,31]. Referring to the I-F system, when the cas I-F genes are present, they are flanked by two
CRISPR repeat arrays named CRISPR4.1 and CRISPR4.2 [24]. In contrast to I-E, these com-
plete I-F systems have larger CRISPR arrays [24] and immunity to foreign elements has been
detected under laboratory growth conditions without induction [20]. However, most E. coli
strains lack cas I-F genes, then containing a single array (CRISPR4.1–2), with a reduced num-
ber of spacers.
A relation between CRISPR and pathogenicity has been illustrated by some remarkable
observations in particular E. coli pathotypes and in other species. For example, a work demon-
strated that CRISPR interference prevents acquisition of capsular virulence genes in Streptococ-
cus pneumoniae [32]. Also, a link of CRISPR elements with serotypes and virulence potential
of Shiga toxin-producing E. coli strains has been established [33]. However, the underlying
cause of this association is unknown. In the context of the immunity role, we hypothesized that
reduced CRISPR activity would pose fewer constraints to the entry of foreign genetic element
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and thus would favor lateral gene transfer (LGT). LGT events constitute one of the major driv-
ing forces in the evolution of prokaryotes [34–37]. Therefore, strains with limited immunity
would be more prone to change their lifestyle [38], such as turning from commensal to patho-
genic. Indeed, commensal E. coli (CEC) strains can become pathogens upon acquisition of vir-
ulence factors [39]. Moreover, infectivity of pathogenic strains could be enhanced after gaining
more of these genes. In order to test whether the association between CRISPR and pathogenic-
ity is a general trend in E. coli, and to shed light on the specific nature of such connection, the
number of CRISPR repeat units in strains of E. coli and related species was compared with the
presence of particular virulence genes involved in pathogenic processes [40,41]. Our results
confirmed the CRISPR-pathogenicity association in E. coli and supported the defensive role of
CRISPR as a driving force contributing to the emergence of pathogenic strains.
Materials and Methods
Strains and growth conditions
The microorganisms analyzed in this work comprise 126 strains (see S1 Table) harboring
homologous CRISPR-Cas systems in equivalent locations [21]. These strains were chosen to
cover a comprehensive range of commensal and pathogenic types, including intestinal
(EnPEC) and extraintestinal (ExPEC) representatives. They consist of 124 E. coli and Shigella
isolates, altogether referred here to as E. coli owing to the fact that both form a coherent phylo-
genetic group [21,42,43], and two strains of closely related species (Escherichia fergusonii
ATCC35469 and Escherichia albertii TW07627). The 72 members of the ECOR collection [44],
are included within the above mentioned panel of 124 E. coli isolates. Hereinafter, the remain-
ing 54 strains will be collectively called non-ECOR. Full or almost completed genomes of these
latter strains are available.
LB medium was typically used for growth of ECOR strains and incubations were carried out
at 37°C for 12h with shaking. Sheep’s blood agar (bioMèrieux, Spain) was used to check hemo-
lytic activity under the same temperature and time conditions.
Pathotype ascription
ECOR strains that had not been previously identified as CEC or within a specific group of path-
ogenicity (i.e., pathotype), were subjected to hemolytic activity tests, a trait frequently linked to
uropathogenic (UPEC) strains, and PCR screened, according to previous procedures [41,45],
to assess the presence of genes usually associated with particular pathotypes (in brackets):
papG (UPEC), einv (enteroinvasive E. coli or EIEC), eaeA (enteropathogenic E. coli or EPEC),
vt1 (enterohemorragic E. coli or EHEC), lt1 (enterotoxigenic E. coli or ETEC) and eagg (enter-
oaggregative E. coli or EAEC). The amplification of any of the enteric markers (einv, eaeA, vt1,
lt1 or eagg) qualified for affiliation to EnPEC (as opposed to UPEC, here considered equivalent
to ExPEC according to [39,46–48]), and the detection of just one of them was initially consid-
ered sufficient to categorize a strain within the respective pathotype. Furthermore, since eaeA
can be additionally found in strains otherwise characterized as non-EPEC [49], those ECOR
members yielding PCR amplifications of eaeA and the signature gene of another enteropatho-
type were ascribed to the latter. Apart from eaeA, if other EnPEC markers were observed
within a strain, its specific pathotype was deemed as not conclusive and thus not considered
for further analyses. Non-amplification of the signature gene of an EnPEC pathotype disquali-
fied for ascription to it. In contrast, as uropathogenic strains frequently lack hemolytic activity
and papG, their absence cannot be considered a sufficient criterion for exclusion from UPEC
[39,45,47]. In consequence, when other uropathogenic determinants such as the kps or sfa
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operon (encoding capsule and S fimbriae respectively) had been reported [40], the strain was
assumed to be UPEC.
Aside from the hemolytic activity usually linked to pathogenicity islands in UPEC, some
EHEC strains can also carry a plasmid-encoded hly operon of similar sequence [39]. Thus,
ECOR strains with the exclusive combination hemolysis-vt1 were considered as EHEC. ECOR
strains harboring other marker gene combinations associated with both EnPEC and ExPEC
were assigned to the group with a higher representation of characteristic genes.
Among non-ECOR strains, only Shigella sp. D9 had not yet been categorized. In this case,
computational searches of EnPEC and ExPEC determinants were performed to infer its
affiliation.
Strains where pathogenic markers were not detected were considered as commensal.
DNA extraction and polymerase chain reactions
DNA for sequencing and polymerase chain reactions (PCR) was extracted from 5 mL LB cul-
tures grown as stated above. Cultures were centrifuged and pellets resuspended in 1 mL of
ultrapure (milliQ) water for a total of three times. Cell suspensions were then lysed by heating
at 98°C for 10 min and cell debris was removed by centrifugation. Finally, the supernatant solu-
tions containing the DNA were stored at -20°C.
PCR amplifications performed to assess the pathogenic affiliation of ECOR strains were
conducted with Taq polymerase (Roche) on a TC-3000 thermal cycler (Techne). Primers and
conditions used are specified in S2 Table.
Retrieval, processing and analysis of sequence data
The number of CRISPR units as well as the sequences of non-ECOR strains analyzed to assess
the presence of genes involved in pathogenicity (i.e., kps, hly, pap, sfa, einv, eaeA, vt1, lt1 and
eagg) were obtained from previous works [21,24,41] or public databases (http://www.xbase.ac.
uk/colibase/; http://www.ncbi.nlm.nih.gov/genomes/). CRISPR spacers were retrieved with
CRISPRFinder [50] available at http://crispr.u-psud.fr/Server/, and similar sequences (over
75% identity) in non-CRISPR loci were searched with the CRISPRTarget tool [51] at http://
bioanalysis.otago.ac.nz/CRISPRTarget/crispr_analysis.html.
For the phylogenetic analysis based on multilocus sequence typing (MLST), partial
sequences from ECOR strains were downloaded from the Environmental Research Institute,
University of Cork (http://MLST.ucc.ie; dinB, icdA, pabB, polB, putP, trpA, trpB and uidA
genes) and from the Institut Pasteur (http://www.pasteur.fr/MLST; adk, fumC, gyrB, icdA,
mdh, purA, and recA genes) web sites. In the case of non-ECOR strains, the same sets of
sequences were retrieved from the abovementioned NCBI and XBASE sites. The concatenated
sequence fragments from each strain were then aligned with CLUSTALW (http://align.
genome.jp/) and a phylogenetic tree was constructed with the programMEGA version 6.06
(http://www.megasoftware.net/), using the UPGMAmethod with distances calculated by the
Jukes-Cantor model on a pairwise-deletion comparison.
Statistical analyses
Statistical analyses were performed with the SPSS software version 17.0 (SPSS 111 Inc., Chi-
cago, IL). Kruskal-Wallis tests were used to infer differences in CRISPR counts. A p-value less
than 0.05 was deemed as significant and validated the possible differences found for each of the
corresponding groupings elaborated in this work of nonpathogenic or any of the pathogenic
strains. Conversely, p-values higher than 0.05 were interpreted as proof of sufficient similarity
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among those groups compared. For robustness, these analyses were performed for groups with
at least 3 strains.
To determine if significant correlations could be found, Pearson and Spearman coefficients
(r) were calculated for the comparisons of different groups of strains with their respective
CRISPR counts. In all cases, p-values lower than 0.05 were accepted for significance.
Results
Distribution of pathogenicity traits across E. coli and closely related
species
As a first step for the comparison between CRISPR content and pathogenicity, strains under
study were classified as either commensal or within a particular pathotype (see S1 Table). In
the case of strains with a previously defined pathogenic profile, the ascription reported was
adopted. Otherwise, the pathotype of Shigella sp. D9 and those ECOR strains not previously
characterized was inferred following the criteria described in Materials and Methods. The
robustness of these criteria was demonstrated by the high degree of coincidence between the
pathotype described for categorized strains and the one predicted after the detection of the
selected pathogenicity markers in the genomes of such strains (S1 Table). Seeming exceptions
in EnPEC genomes were the E. coli strains P12b and 101.1, previously assigned to EPEC and
EAEC respectively, where we did not find the corresponding markers (eaeA and eagg). Never-
theless, these results were in agreement with reports for other strains [49,52–55], indicating
that eaeA and eaggmight not be considered as signatures invariably linked to the respective
pathogenic group. In the case of the UPEC/ExPEC strains, our marker-based ascriptions were
also highly coincident with pathogenicity documented. The most striking difference involved
strain EC23, which showed hemolytic activity (encoded by the hly operon) in our tests and
papG was amplified, even though these UPEC genes had not been detected in a previous South-
ern analysis [40]. This inconsistency might be due to low sequence conservation in this strain
of the probes used in the Southern blot analyses. Another somehow unexpected result was the
finding of some UPEC traits in several strains that had been deemed to be CEC or EnPEC (S1
Table), which could be attributed to the great genome plasticity found in E. coli and the fact
that genes, while present, may not necessarily be expressed [56,57]. This prompted us to ascribe
pathogenicity solely based on the nature and number of the ExPEC or EnPEC virulence traits.
Comparison of repeat content with pathogenicity
Once strains were catalogued as commensal or with a specific pathotype, this profile was com-
pared with the number of CRISPR2 repeats (see S1 Table) and statistical analyses were con-
ducted. A strong negative correlation was found between the CRISPR2 repeat count and the
possession of pathogenic traits (Pearson’s r = -0.465, with p = 0.01 for comparison A of all
strains in S1 Table). Generally, the median number of repeats for CEC strains was higher than
for pathogenic strains (29.5 vs. 12.0 with p = 0.000; see comparison A for all strains in Table 1).
Moreover, differences in the count of CRISPR2 units were also observed between ExPEC and
EnPEC. In accordance with previous results [58], ExPEC pathogens usually carried fewer
repeats than CEC. Furthermore, this number was lower than for EnPEC strains (2 in ExPEC
compared to 18 in EnPEC; see Fig 1, S1 Table and comparison B in Table 1, N = 126), with a
Pearson’s correlation coefficient of r = -0.591 for a significance value of p = 0.01 (Fig 2A). In
contrast, differences in repeat numbers for the diverse EnPEC pathotypes were not significant
(p>0.07, comparison C in Table 1, N = 126). Furthermore, no statistically significant distinc-
tion (p = 0.887) could be made between ECOR strains carrying enteric markers and non-
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ECOR EnPEC members (comparison D in Table 1, N = 126). This equivalence between both
sets of strains confirmed the overall validity of our PCR analyses. However, it should be noted
that range values (minimum and maximum no. of CRISPR units) within each group consid-
ered in Table 1 were larger than those found in similar studies [33,58]. This hints to a higher
strain diversity within the groups considered in this work (see discussion).
The inclusion in this study of strains lacking cas I-E genes (hence with a similarly reduced
repeat number) might generate distorted results due to a possible clonal effect. However, when
comparisons were performed for the subset of 71 strains carrying a complete set of cas I-E, the
results were highly coincident with those obtained for all strains (Table 1). The only exception
corresponded to the lack of discrimination (p = 0.172) between EnPEC and ExPEC (Fig 1, S1
Table and comparison B in Table 1, N = 71). However, strong negative correlation values were
still found between repeat numbers and pathotype (Pearson’s r = -0.465, with p = 0.01, see Fig
2B). These results with the purged set of 71 strains suggest that cas I-E functionality, rather
than a phylogenetic (i.e. clonal) constraint, would be the main cause of the relationship found
between CRISPR and pathogenicity. To provide further support to this conclusion, the distri-
bution within phylogroups A and B1 of pathogenic and commensal strains with a complete set
of cas I-E genes was analyzed [21]. These two phylogenetically related MLST groups were
selected for the analysis since they include the majority of cas I-E harboring strains (N = 52).
The results obtained showed that CEC and pathogenic strains were present across all the major
phylogenetic subgroups within A and B1 (S1 Fig). In spite of this scattered distribution, a nega-
tive correlation (see S2 Fig) could still be observed when comparing CEC, EnPEC and ExPEC
with their CRISPR repeat counts, with a Pearson coefficient of r = -0.476 for a significance of
p = 0.01. This observation in strains sharing the same phylogenetic constraints further hints
that CRISPR-Cas systems may influence, at least partially, on pathogenicity.
Table 1. Groups of strains studied for which statistical comparisons of repeat content and pathogenicity were performed.
All strains (N = 126) Strains with intact I-E genes (N = 71)
Comparison Group of strains
compared
No. of
strains
Median repeat
no.
Repeat no.
range
No. of
strains
Median repeat
no.
Repeat no.
range
A 1. Commensal 28 29.5 0–53 22 38.0 6–53
2. Pathogenic 98 12 0–42 49 21.0 5–42
B 1. Commensal 28 29.5 0–53 22 38.0 6–53
2. EnPEC 50 18 0–42 35 23.0 11–42
3. ExPEC 43 2 0–29 11 19.0 5–29
C 1. EIEC 9 10 3–42 3 24.0 15–42
2. EPEC 10 14 0–33 6 17.5 9–33
3. ETEC 5 23 12–40 4 26.0 22–40
4. EHEC 17 21 6–35 16 25.0 7–35
D 1. EnPEC (ECOR) 41 13 0–42 23 25.0 2–42
2. EnPEC (non-ECOR) 31 14 0–40 18 19.0 2–40
E 1. n = 0 UPEC genesa 63 21 0–53 49 26 6–53
2. n = 1 UPEC genesa 23 13 0–29 12 20.5 7–29
3. n = 2 UPEC genesa 22 2 0–31 9 19 14–31
4. n = 3 UPEC genesa 7 2 1–5 1 5 -
5. n = 4 UPEC genesa 11 2 0–2 0 - -
aStrains with the same total number of UPEC factors considered in the study.
doi:10.1371/journal.pone.0131935.t001
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Fig 1. Comparison of CRISPR counts and pathogenic categories.Median numbers of CRISPR2 units in
commensal (CEC), enteric (EnPEC) or extraintestinal (ExPEC) pathogens of the E. coli and related strains
analyzed in this study, are indicated by a horizontal line. Light grey boxes represent the interquartile range
values for the whole set of 126 strains (with 28, 50 and 43 isolates for each group, respectively). Dark grey
boxes comprise the interquartile range values for the reduced subset of 71 strains with intact cas I-E genes
(22, 35 and 11 isolates). Vertical lines for each box denote the corresponding CRISPR2 count range.
Significant differences of median values (Kruskal-Wallis p-values lower than 0.05) for the comparisons within
each of these two sets of strains are indicated by an asterisk (ns, not significant).
doi:10.1371/journal.pone.0131935.g001
Fig 2. Correlation of CRISPR counts and pathogenic categories.Graphical representation of the number of CRISPR repeats in strains categorized as
commensal (CEC) or as pathogens of enteric (EnPEC) or extraintestinal (ExPEC) origins for the whole set of N = 126 strains (A) or the 71 strains with the
intact set of cas I-E genes (B). Dotted lines represent the least-square linear regressions, and their corresponding R2 values are indicated.
doi:10.1371/journal.pone.0131935.g002
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In the case of the I-F system, the associated cas genes were only detected in 14 strains of
those under study, the majority being pathogenic (S1 Table). This suggested a much reduced
impact on pathogenicity of I-F compared to I-E.
Higher numbers of uropathogenicity genes relate to lower repeat counts
In contrast to EnPEC pathotypes where just one pathogenicity factor was considered in this
study, a total of four markers were probed for UPEC. This allowed us to perform an analysis in
this latter case to assess a correlation between the repeat count and the number of such patho-
genic traits within each strain. This analysis showed that, regardless of their classification as
pathogen or commensal, strains with the lowest number of repeats tended to bear more of such
factors (Fig 3, S1 Table and comparison E in Table 1, N = 126), showing a strong negative cor-
relation (Spearman’s r = -0.622, p = 0.01, see Fig 4A). Furthermore, strains in possession of 1
uropathogenic determinant had six times more CRISPR units than those carrying 2 or more
(Fig 3, S1 Table and comparison E in Table 1, N = 126), ranging from 13 repeats (1 factor) to 2
Fig 3. Comparison of the CRISPR counts and the number of UPEC genes.Median numbers of CRISPR2
units in the strains under study, referred to the number of selected uropathogenicity genes within those
strains. For each UPEC number category (x-axis), light grey boxes represent the interquartile range for the
median value (horizontal line) of all strains (N = 126, with 63, 23, 22, 7 and 11 isolates for each category,
respectively), while dark grey boxes indicate that value for strains with complete cas I-E genes (N = 71 and
49, 12, 9, 1 and 0 isolates, respectively). Vertical lines indicate the CRISPR2 count ranges. Significant
differences of median values (Kruskal-Wallis p-values lower than 0.05) for the comparisons within each set of
strains are indicated by an asterisk (ns, not significant). The categories compared are indicated in brackets,
while categories with an insufficient number of isolates are not considered for comparison (see Materials and
Methods).
doi:10.1371/journal.pone.0131935.g003
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(2–4 factors). This suggested a relationship between CRISPR activity and the capability to
incorporate such pathogenic factors. Thus, it could be inferred that a greater virulence potential
(in terms of a higher number of factors) is associated with lower repeat counts. However, while
Kruskal-Wallis tests differentiated (in terms of CRISPR count) between strains with 1 or no
UPEC factors from the rest, they did not discriminate between strains with 2, 3 or 4 UPEC fac-
tors (p>0.05 in all cases, see Fig 3). This lack of differentiation might suggest a certain degree
of specialization at least in uropathogenicity, where a critical number of virulence determinants
should be required to elicit pathogenicity. This conclusion is further supported when consider-
ing that, of the 16 strains with a previously defined pathotype that were in possession of just 1
UPEC factor (see S1 Table), only in 2 was the reported pathotype UPEC/ExPEC, whereas in
the rest was either CEC (4 strains) or EnPEC (10 strains). In contrast, of the 20 previously
ascribed strains carrying 2 to 4 UPEC factors, 19 had been deemed as uropathogens [44,59–
63].
When strains without cas I-E genes were purged, an almost 4-fold difference in repeat
counts between strains with 1–2 versus 3 factors (19 vs 5, S1 Table and comparison E in
Table 1, N = 71) was observed, with strong negative correlation values (Spearman’s r = -0.320,
with p = 0.01, see Fig 4B). Nevertheless, the fact that just one isolate contained 3 factors did not
allow us to assess significance for all the groups compared, albeit p = 0.007 was obtained to dif-
ferentiate between strains carrying no UPEC determinants and those with at least one of them
(Fig 3). These results for the 71 strains, coupled with those from the same subset regarding
CEC, EnPEC and ExPEC groupings, strongly suggest that loss of CRISPR activity allowed
ExPEC specialization, and that this loss was more often accomplished by the removal of the cas
I-E genes.
Correlation between CRISPR-Cas I-E repeat numbers and
pathogenicity in other Escherichia species
The E. fergusonii ATCC35469 and E. albertii TW07 strains included in this study showed the
general pattern of correlation between pathogenicity and CRISPR counts observed in E. coli
(S1 Table). Thus, the commensal E. fergusonii strain ATCC35469 [64] has a number of repeat
Fig 4. Correlation of CRISPR counts and the number of UPEC genes.Graphical representation of the number of CRISPR repeats for strains harboring 0,
1, 2, 3 or 4 UPEC factors for the whole set of N = 126 strains (A) or the 71 strains with the intact set of cas I-E genes (B). Dotted lines represent the least-
square linear regressions, and their corresponding R2 values are indicated.
doi:10.1371/journal.pone.0131935.g004
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units (n = 38) within the range of the median values found for CEC (n = 29.5 or n = 38,
depending on the set comprising all strains or the one purged of cas-less strains, respectively),
and the CRISPR unit count in the enteropathogenic E. albertii TW07627 [65] is on par with
the median values encountered in the EnPEC isolates. Taken together, these results further
support a link between the I-E CRISPR-Cas system and the pathogenicity of E. coli-related
microorganisms.
Discussion
Impact of the I-E CRISPR-Cas system on the pathogenicity of
Escherichia
A negative correlation has been established in this work between the repeat content in the I-E
system and the pathogenicity of E. coli and related strains. However, several explanations could
account for this relationship. In principle, it could be interpreted as the consequence of the
immunity role of CRISPR: those systems with higher numbers of spacers, as a result of a higher
mean activity [26], will act as more efficient barriers against invaders, such as those carrying
virulence factors that promote pathogenicity [39,46,64,66]. Although the immune function has
been proven in other species, the apparently low dynamics of the CRISPR arrays of E. coli sug-
gests that they do not act as would be expected for an efficient barrier [30]. Nevertheless, the
low turnover of spacers should be seen as a consequence of the stringent regulation that gov-
erns expression of CRISPR-Cas I-E [17,67–70], being silenced under normal growth conditions
[17,67]. Moreover, laboratory strains are able to elicit CRISPR-mediated interference against
plasmids and phages [69,71] and the widespread presence in E. coli strains of spacers with iden-
tities to viral and plasmid sequences [24] strongly supports the defense role of CRISPR-Cas.
Indeed, a search for spacer homologs revealed that 98 out of the 114 strains studied harboring
spacers have at least one that matches sequences in transmissible elements (S1 Table).
A previous work on E. coli reported no meaningful association between the presence in the
cell of cas I-E genes and that of plasmids [31], arguing against a role of the I-E system as a bar-
rier to the import of a genetic element. However, I-E spacers target mainly phages, with a rela-
tively low proportion of plasmids [20], with a ca. five to one ratio for these elements,
respectively (see S1 Table). These results suggest that I-E would preferentially limit viruses and,
in the context of pathogenicity, CRISPR would be mainly hindering acquisition of virulence
factors carried by these infectious elements. By contrast, the phage-plasmid ratio of spacer
homologs in those strains carrying the less prevalent I-F is 24 to 43, albeit 15 of the plasmid
homologs are found within a single CEC isolate (strain ED1a, see S1 Table). Remarkably, ED1a
and Shigella sp. D9 are the only CEC strains carrying I-F whereas the rest are pathogenic. In
this sense, it should be noted that, whereas some of the EnPEC markers considered in this
work (namely einv and eagg) may be carried by plasmids, they are also present as part of chro-
mosomal pathogenicity islands which, due to their size, are usually located within prophages or
in association with transposons [39]. Thus, the potential association of I-F on pathogenicity,
despite being more active than I-E [20] seems, due to its affinity to genetic elements and low
prevalence, more negligible than I-E.
An alternative explanation for the CRISPR-pathogenicity association is that the I-E system
may be related to regulation of expression of virulence genes, as has been seen in other micro-
organisms where Cas proteins enable or increase pathogenicity [72,73]. However, if a regula-
tory involvement would apply to the E. coli systems, such role should be as a repressor rather
than inducer (less active system in more pathogenic strains). Moreover, repeat counts should
not be directly related to this activity [72]. Thus, the variations in the number of repeat-spacer
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units must reflect foreign attacks (immunization), and consequent targeting activity rather
than regulation of virulence factors.
These findings suggest that CRISPR activity may have hindered the emergence of pathogenic
lifestyles in E. coli [73]. Alternatively, our results could be interpreted the other way around: that
the pathogenic behavior promoted a reduced activity of CRISPR-Cas elements. However, the
ancestral presence in Escherichia of the CRISPR systems, altogether with the absence of cas genes
in pathogenic groups, notably of I-E subtype in the B2 group of MLEE strains [21], disputes the
latter possibility. Regarding E. coli phylogeny, the subset of strains with functional I-E systems,
which mainly belong to closely related MLEE groups A and B1 [21], follows the same correlation
of repeat counts and pathogenicity (as mentioned above). This fact should be considered as
another indication of the role of CRISPR activity on pathogenicity, as opposed to the repeat dis-
tribution being merely the result of a phylogenetic constraint.
Relationship between habitat and CRISPR-Cas activity
In the context of CRISPR acting as an immune system, differences in its activity among strains
would be expected, for instance due to genetic diversity or the varied inducing factors they
encounter in their respective habitat. These factors include the frequency they face invaders,
the diversity of such invaders or the occurrence of mutations in the target that will prompt effi-
cient acquisition [26,71,74,75]. Certainly, a link between the habitat to which the strains adapt
and CRISPR activity is supported by the differences we found in the repeat content between
intestinal and extraintestinal strains. However, CEC strains carry a significantly higher number
of repeats than EnPEC, even though the members of both groups share habitat, being confined
almost exclusively within the gut. This difference in repeat counts could be explained by a dif-
ferent frequency of successful events of lateral gene transfer (LGT) in commensal and patho-
genic strains. Indeed, the gut is a bacteriophage-rich environment [76,77], where strong
selective pressure must exist favoring the occurrence of efficient mechanisms preventing phage
infection. Nevertheless, taking into account that phages are also an important source of viru-
lence factors, it is expected that EnPEC strains will have more permissive (i.e., less active)
defense systems against these infective agents than CEC.
In the case of ExPEC strains, which also colonize secondary habitats where viral predators
are scarcely present [78,79], less selective pressure together with the above stated advantage for
a pathogen to allow LGT, would justify a further reduction in CRISPR activity.
CRISPR count diversity reveals a notable heterogeneity of pathogenic
populations of E. coli
The large interquartile ranges of many CRISPR counts that were found within CEC and each
of the pathotypes (both in ECOR and non-ECOR strains) suggested the existence of very
diverse populations within each group. Several reasons could account for such dispersion. For
instance, the contribution of barriers alternative to CRISPR-Cas, which may compensate a
reduced CRISPR activity (i.e., low repeat counts) in some commensal strains. Similarly, patho-
genic strains may possess exceptionally active CRISPRs that would counterbalance the lack of
alternative barriers. Nevertheless, an inaccurate ascription of some strains within each group
(e.g. some pathogenic strains having been deemed to be commensal or vice versa) cannot be
dismissed. Indeed, this categorization is error-prone as pathogenicity is a complex process.
Among others, factors such as medical procedures performed on patients, their general health
status, the molecular affinity of microbial pathogenic gene products for a specific host, and
hence different levels of virulence could alter the outcome to either pathogenic or commensal
[80–82]. Otherwise, in the case of strains where an established pathogenicity profile was not
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available, we inferred it by the presence of traits characteristic of a specific pathotype. Never-
theless, the presence of a particular trait does not determine pathogenicity, since it might not
be functional [56]. Moreover, as observed here in the case of UPEC strains, true pathogenicity
might require a certain critical number of virulence traits. This biased marker-based ascription
might certainly account for at least some of the apparent intra-pathogroup diversity
encountered.
Conclusions
A correlation has been established linking a reduced repeat content in the I-E system of Escher-
ichia coli and related strains with a higher probability for a specific strain to exert pathogenicity
(i.e. the potential ability of a microorganism to cause disease). Moreover, significant differences
in the CRISPR count also correlate with the environment in which this pathogenicity is per-
formed, despite all strains normally reside in the gut. However, the great variability in the num-
ber of CRISPR units for strains within a pathogenic group would make its potential application
for predictive studies of pathogenicity best suited as supplementary to other techniques. The
increase in genomic data and a more accurate characterization of the strains (E. coli and other
species) in terms of their pathogenic profile and their particular CRISPR-Cas activity will pro-
vide new clues to better understand this correlation. Nevertheless, the influence of CRISPR-Cas
as a barrier regulating the influx of LGT, and the subsequent impact on the diversity of E. coli
and related species, should be a factor to be considered to better understand gene exchange
phenomena from an evolutionary standpoint.
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